2020 Japan Coagulation Testing Lab and POC Market: Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
Summary
This comprehensive report contains 402 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Japanese coagulation testing market during the next five years.
The report explores business and technological trends in the Japanese coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
This comprehensive report contains 402 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Japanese coagulation testing market during the next five years.
The report explores business and technological trends in the Japanese coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
- Comprehensive market segmentation analysis, including:
- Hospitals
- Commercial/Private Laboratories
- Test volume forecasts for over 40 major procedures by market segment.
- Review of established and emerging procedures.
- Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
- Analysis of current and emerging technologies and their potential market applications.
- Comprehensive lists of companies developing or marketing new technologies and products by test.
- Product development and business expansion opportunities with significant market appeal.
- “Ideal” product models with tentative prices and operating characteristics.
- Alternative market penetration strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.
More Publications
Japan Diagnostic Analyzers and Reagents Market, 2019-2023: Supplier Shares by Test, Segment Forecasts, Market Structure, Business Environment
US$ 3,450.00
July 2019
60 pages
2019 Japan Endocrine Function Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
US$ 1,850.00
April 2019
269 pages
Japan Molecular Diagnostics Market 2017: Sales and Market Shares of Major Suppliers
US$ 3,000.00
July 2017
121 pages
Japan Drugs of Abuse: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
US$ 2,200.00
June 2016
260 pages
2019-2023 Japan Microbiology Automated Market: Supplier Shares and Strategies, Country Segment Forecasts, Technology and Instrumentation Review--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
US$ 8,850.00
February 2019
421 pages
